MGUS PN Flashcards
What percentage of people over 70 have MGUS?
5.3%
What percentage of patients with MG-IgM develop peripheral neuropathy?
50% of patients with MG-IgM develop peripheral neuropathy.
What is the role of protein electrophoresis in evaluating M-protein?
It quantitatively evaluates the M-protein when detectable.
What information does immunofixation provide about M-protein?
Subtype of M-protein (also very sensitive for M protein)
Which size fibers are mainly affected in DADS?
Large sensory fibers.
What symptoms are usually presented in DADS?
Distal hypoesthesia, sensory ataxia, and minimal or no weakness.
What percentage of DADS patients have no detectable IgM MG?
One-third of DADS patients have no detectable IgM MG.
What is the CIDP variant called when DADS patients lack IgM MG?
It is referred to as distal CIDP.
What percentage of DADS cases with IgM MG present anti-MAG antibodies?
67% of DADS cases with IgM MG present anti-MAG antibodies.
What MAG antibody BTU titer is less likely to be related to neuropathy?
Titers smaller than 8000 BTU are less likely related to neuropathy.
Nerve conduction studies show what key findings in anti-MAG-associated neuropathies?
Disproportionally prolonged distal motor latency and reduced conduction velocity.
What terminal latency index (TLI) value increases likelihood of anti-MAG-associated neuropathies?
TLI < 0.26 increases likelihood.
Are conduction block and temporal dispersion common in anti-MAG-associated neuropathies?
No, they are rarely seen.
What is the most common syndrome associated with anti-MAG antibodies?
DADS is the most common syndrome associated with anti-MAG antibodies.
What is the response to corticosteroids or immunoglobulin in IgM-MGUS with anti-MAG neuropathy?
Little to no response.
What is the first-line drug for IgM-MGUS with anti-MAG neuropathy?
Rituximab.
What percentage of patients treated with rituximab achieve a good clinical response?
Need to clarify context of this question)
Less than 50% of cases.
What was the clinical outcome for patients treated with ibrutinib in a small case series for IgM anti MAG demyelinating PN?
Early and persistent clinical response.
What are the hallmark features of the chronic ataxia syndromes caused by IgM disialosyl antibodies (CANOMAD and CANDA)?
Pure sensory ataxia, areflexia, minimal motor involvement, with or without ophthalmoplegia.
What does the complete presentation of CANOMAD include?
Chronic ataxic neuropathy, ophthalmoplegia, IgM paraprotein, cold agglutinins, disialosyl antibodies.
What is absent in the incomplete form CANDA compared to CANOMAD?
External ocular muscles weakness and cold agglutinins.
What type of antibodies are frequently detected in the CANOMAD/CANDA?
Anti-ganglioside antibodies, especially against disialosyl-type epitopes (GD1b, GD3, GT1b, GQ1b).
Slowed CV are seen in most CANOMAD/CANDA but what percentage of patients may show normal motor conduction velocities with reduced amplitudes?
Up to 27% of patients.